trial · primary record
Anastrozole
Breast Ductal Carcinoma In Situ
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 5018 |
| Primary completion | 2027-01-08 |
| Primary endpoint | Invasive Disease-Free Survival (IDFS) |
| Registry ID | NCT01272037 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:38.006Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT01272037
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.